The factors driving market growth include rapid growth in the oncology drugs market, growing demand for antibody drug conjugates, increasing focus of pharmaceutical companies on HPAPIs, and advancements in HPAPI technologies. However, factors such as stringent regulatory requirements and requirement of large investments may restrain the market growth.